| Device |
anti-glutamate receptor (type nmda) ifa |
| Regulation Description |
Multiple autoantibodies immunological test system. |
| Definition |
Intended for the qualitative determination of autoantibodies against glutamate receptor (type NMDA) in human serum. Used as an aid in the diagnosis of anti-glutamate receptor (type NMDA) autoimmune encephalitis in conjunction with other laboratory and clinical findings. |
| Physical State |
Solid, liquid |
| Technical Method |
Immunofluorescent assay with multiple substrates |
| Target Area |
Human serum |
| Regulation Medical Specialty |
Immunology |
| Review Panel |
Immunology |
| Product Code | OSK |
| Premarket Review |
Office of In Vitro Diagnostics
(OHT7)
Division of Immunology and Hematology Devices
(DIHD)
|
| Submission Type |
510(k)
|
| Regulation Number |
866.5660
|
| Device Class |
2
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction Reporting |
Eligible |
| Implanted Device? |
No
|
| Life-Sustain/Support Device? |
No
|
|
Third Party Review
|
Accredited Persons
|